866-997-4948(US-Canada Toll Free)

United States Nuclear Medicine & Radio Pharmaceuticals Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 102 Pages

In this report, the United States Nuclear Medicine & Radio Pharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals in these regions, from 2012 to 2022 (forecast).

United States Nuclear Medicine & Radio Pharmaceuticals market competition by top manufacturers/players, with Nuclear Medicine & Radio Pharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GE Healthcare
Philips Healthcare
Siemens Healthcare
Toshiba
Hitachi
Carestream
Esaote
Shimadzu
TriFoil Imaging
Biosensors International Group, Ltd

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals for each application, including
Diagnostic Applications: SPECT, PET.
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Nuclear Medicine & Radio Pharmaceuticals Market Report 2017
1 Nuclear Medicine & Radio Pharmaceuticals Overview
1.1 Product Overview and Scope of Nuclear Medicine & Radio Pharmaceuticals
1.2 Classification of Nuclear Medicine & Radio Pharmaceuticals by Product Category
1.2.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
1.2.4 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
1.3 United States Nuclear Medicine & Radio Pharmaceuticals Market by Application/End Users
1.3.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Diagnostic Applications: SPECT, PET.
1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.4 United States Nuclear Medicine & Radio Pharmaceuticals Market by Region
1.4.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.4.3 Southwest Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.4.5 New England Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.4.6 The South Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.4.7 The Midwest Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Nuclear Medicine & Radio Pharmaceuticals (2012-2022)
1.5.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2022)
1.5.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2022)

2 United States Nuclear Medicine & Radio Pharmaceuticals Market Competition by Players/Suppliers
2.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Nuclear Medicine & Radio Pharmaceuticals Average Price by Players/Suppliers (2012-2017)
2.4 United States Nuclear Medicine & Radio Pharmaceuticals Market Competitive Situation and Trends
2.4.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Concentration Rate
2.4.2 United States Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nuclear Medicine & Radio Pharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type

3 United States Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Region (2012-2017)
3.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Region (2012-2017)
3.3 United States Nuclear Medicine & Radio Pharmaceuticals Price by Region (2012-2017)

4 United States Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Type (2012-2017)
4.3 United States Nuclear Medicine & Radio Pharmaceuticals Price by Type (2012-2017)
4.4 United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Type (2012-2017)

5 United States Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Application (2012-2017)
5.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Application (2012-2017)
5.2 United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Nuclear Medicine & Radio Pharmaceuticals Players/Suppliers Profiles and Sales Data
6.1 GE Healthcare
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Philips Healthcare
6.2.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Siemens Healthcare
6.3.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Toshiba
6.4.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Hitachi
6.5.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Carestream
6.6.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Esaote
6.7.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Shimadzu
6.8.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 TriFoil Imaging
6.9.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Biosensors International Group, Ltd
6.10.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Cost Analysis
7.1 Nuclear Medicine & Radio Pharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Forecast by Type (2017-2022)
11.3 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Forecast by Application (2017-2022)
11.4 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Nuclear Medicine & Radio Pharmaceuticals
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Size (K Units) by Type (2012-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Product Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Product Picture
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Application in 2016
Figure Diagnostic Applications: SPECT, PET. Examples
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure The West Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) and Growth Rate (2012-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players/Suppliers
Figure 2017 United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Players/Suppliers
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players/Suppliers
Figure 2017 United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Players/Suppliers
Table United States Market Nuclear Medicine & Radio Pharmaceuticals Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Nuclear Medicine & Radio Pharmaceuticals Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 3 Players/Suppliers
Figure United States Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nuclear Medicine & Radio Pharmaceuticals Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nuclear Medicine & Radio Pharmaceuticals Product Category
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Region (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Region (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Region (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Region in 2016
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Region (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Region in 2016
Table United States Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) by Region (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Type (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type in 2016
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type in 2016
Table United States Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) by Types (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Type (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales (K Units) by Application (2012-2017)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application in 2016
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2012-2017)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Philips Healthcare Basic Information List
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Toshiba Basic Information List
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Hitachi Basic Information List
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Carestream Basic Information List
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Esaote Basic Information List
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Shimadzu Basic Information List
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table TriFoil Imaging Basic Information List
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Biosensors International Group, Ltd Basic Information List
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales Market Share in United States (2012-2017)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine & Radio Pharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Players/Suppliers in 2016
Table Major Buyers of Nuclear Medicine & Radio Pharmaceuticals
Table Distributors/Traders List
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Type in 2022
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Application in 2022
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *